Aspiration of excess follicles before intrauterine insemination in high response cycles
dc.contributor.author | Prieto Molano, María Begoña | |
dc.contributor.author | Díaz Núñez, María | |
dc.contributor.author | Laínz, Lucía | |
dc.contributor.author | Vendrell, Alberto | |
dc.contributor.author | Rabanal Nuñez, Aintzane | |
dc.contributor.author | Iglesias Calabria, María | |
dc.contributor.author | Jauregui, Teresa | |
dc.contributor.author | Corcóstegui, Beatriz | |
dc.contributor.author | Matorras, Ana | |
dc.contributor.author | Pérez, Silvia | |
dc.contributor.author | Matorras Weinig, José Roberto | |
dc.date.accessioned | 2022-10-10T16:42:57Z | |
dc.date.available | 2022-10-10T16:42:57Z | |
dc.date.issued | 2022 | |
dc.identifier.citation | Reproductive Medicine and Biology 21(1) : (2022) // Article ID e12470 | es_ES |
dc.identifier.issn | 1445-5781 | |
dc.identifier.issn | 1447-0578 | |
dc.identifier.uri | http://hdl.handle.net/10810/57955 | |
dc.description.abstract | Purpose To assess the outcome of excess follicle aspiration before intrauterine insemination (EFABI) in intrauterine insemination (IUI) cycles with 4-6 follicles >= 14 mm. Methods A retrospective case-control study with 1559 patients undergoing IUI (donor and husband's sperm), of whom 86 underwent EFABI. We studied also an historical series of 2213 patients before EFABI implementation. For 3.5 years, all women undergoing IUI developing 4-6 follicles >= 14 mm were offered EFABI on the day of hCG administration. Pregnancy rates (PRs), multiple PRs, and adverse effects were measured. Results EFABI was associated with a similar multiple PR (17.8% vs 17.5% in non-EFABI cases), with no triplets in EFABI patients. Live birth rates were significantly higher in EFABI cycles in IUI overall (25.5% vs 15.2%). When considered separately, the performance of EFABI resulted in significantly increased live birth rates in IUI-donor cycles (32.5% vs 18.5%), whereas the differences in IUI-husband cycles (19.5% vs 12.9%) did not reach statistical significance. The PR was 21.2% during the EFABI implementation period and 19.4% in the pre-EFABI period. Conclusions EFABI in cycles in which 4-6 follicles reach >= 14 mm is a simple option that reduces cycle cancellation rates, results in higher PRs than cycles with 1-3 follicles, and lowers the risk of multiple pregnancy. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Wiley | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/es/ | * |
dc.subject | follicular aspiration | es_ES |
dc.subject | hyperresponse | es_ES |
dc.subject | intrauterine insemination | es_ES |
dc.subject | multiple pregnancy | es_ES |
dc.subject | pregnancy rate | es_ES |
dc.title | Aspiration of excess follicles before intrauterine insemination in high response cycles | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.rights.holder | © 2022 The Authors. Reproductive Medicine and Biology published by John Wiley & Sons Australia, Ltd on behalf of Japan Society for Reproductive Medicine. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. | es_ES |
dc.rights.holder | Atribución-NoComercial-SinDerivadas 3.0 España | * |
dc.relation.publisherversion | https://onlinelibrary.wiley.com/doi/10.1002/rmb2.12470 | es_ES |
dc.identifier.doi | 10.1002/rmb2.12470 | |
dc.departamentoes | Especialidades médico-quirúrgicas | es_ES |
dc.departamentoeu | Medikuntza eta kirurgia espezialitateak | es_ES |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's license is described as © 2022 The Authors. Reproductive Medicine and Biology published by John Wiley & Sons Australia, Ltd on behalf of Japan Society for Reproductive Medicine.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.